When a team scores a touchdown in football, often one sees a player spike the ball in celebration. The equivalent of spiking a ball rarely happens in medicine. That being said, a recent study (Hepatology 2015; 61: 41-45) indicates that after treatment sofosbuvir regimens, you can celebrate if you have a sustained virological response (SVR) at 12 weeks (SVR12).
The authors conducted a retrospective review of five trials with 863 patients with HCV genotypes 1-6. “Of the 779 patients with an SVR12, 777 (99.7%) also achieved an SVR24.” Of the patients who relapsed, most (77.6%) did so within 4 weeks of completing therapy.
Related blog posts:
gutsandgrowth 